Loading…
Boundless Bio, Inc. is projected to rise to $1.68 by 2027, a +14% move from its current price of $1.47. BOLD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.43 | $1.47 | $1.51 | -0.01% |
| May 30 | $1.41 | $1.47 | $1.53 | -0.03% |
| May 31 | $1.40 | $1.47 | $1.54 | -0.04% |
| Jun 1 | $1.39 | $1.47 | $1.55 | -0.05% |
| Jun 2 | $1.38 | $1.47 | $1.56 | -0.06% |
| Jun 3 | $1.37 | $1.47 | $1.57 | -0.08% |
| Jun 4 | $1.37 | $1.47 | $1.58 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.37 | $1.47 | $1.58 | -0.09% |
| Week 2 | $1.32 | $1.47 | $1.63 | -0.18% |
| Week 3 | $1.29 | $1.47 | $1.66 | -0.27% |
| Week 4 | $1.27 | $1.46 | $1.70 | -0.36% |
| Week 5 | $1.24 | $1.46 | $1.72 | -0.45% |
| Week 6 | $1.22 | $1.46 | $1.75 | -0.54% |
| Week 7 | $1.20 | $1.46 | $1.77 | -0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Boundless Bio, Inc. is a healthcare company at the clinical stage focused on oncology. It develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers.
Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor subtype.
Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Boundless Bio, Inc. (BOLD) is a healthcare stock with a current price of $1.44 and a market capitalization of $32.35M. It ranks 4780 among listed equities.
The 30-day price dynamics show a range from $1.19 to $1.74, reflecting the near-term trading band around the current level.
Forecasts imply a gradual price path, with the average price near $1.44 in 2026, rising to $1.66 by 2030 and further higher in later years, ending at an average of $6.63 by 2050. The sentiment trough remains NEUTRAL through 2030, turning BULLISH from 2031 onward.
A major floor 28.6% below — a decisive break under it would weaken the trend.
The nearest floor, 4.8% below — buyers have tended to step in here.
The nearest ceiling, 10.9% above — a clean break opens room to run.
A major ceiling 17.7% above — clearing it would confirm fresh momentum.
Key BOLD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BOLD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.45 | Buy | $1.46 | Buy |
| MA 10 | $1.46 | Buy | $1.46 | Buy |
| MA 20 | $1.49 | Sell | $1.47 | Buy |
| MA 50 | $1.37 | Buy | $1.40 | Buy |
| MA 100 | $1.27 | Buy | $1.33 | Buy |
| MA 200 | $1.24 | Buy | $1.43 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.77 | Neutral |
| Stoch RSI (14) | 42.72 | Neutral |
| CCI (20) | -30.22 | Neutral |
| Williams %R (14) | -53.33 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | 2.08 | Buy |
| Bollinger %B (20,2) | 0.40 | Neutral |
| Stochastic %K (14) | 46.67 | Neutral |
| TRIX (15) | 0.29 | Buy |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 42.97 | Neutral |
| Momentum (10) | -0.03 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 1.46 | Buy |
| ADX (14) | 14.39 | Neutral |
| ATR (14) | 0.04 | Info |
The near-term technical picture is NEUTRAL. RSI14 is 50, with SMA50 at $1.36 and SMA200 at $1.24, suggesting limited short-term directional momentum.
Support is priced at $1.20 and resistance at $1.63, with a 30-day trading range from $1.19 to $1.74. Annualized volatility stands around 60%, indicating notable price movement potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.05 | $1.47 | $2.06 | 0% | Neutral | |
| $1.33 | $1.68 | $2.25 | +14% | Neutral | |
| $1.31 | $1.71 | $2.37 | +16% | Neutral | |
| $1.27 | $1.68 | $2.40 | +14% | Neutral | |
| $1.27 | $1.72 | $2.52 | +17% | Neutral | |
| $1.45 | $2.00 | $2.99 | +36% | Bullish | |
| $1.63 | $2.30 | $3.49 | +56% | Bullish | |
| $1.72 | $2.45 | $3.79 | +67% | Bullish | |
| $1.71 | $2.47 | $3.89 | +68% | Bullish | |
| $1.70 | $2.50 | $3.99 | +70% | Bullish | |
| $2.20 | $3.46 | $5.88 | +136% | Bullish | |
| $3.82 | $6.76 | $12.56 | +360% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.05 | $1.47 | $1.73 | +0.00% |
| June 2026 | $1.26 | $1.48 | $1.78 | +0.79% |
| July 2026 | $1.23 | $1.45 | $1.77 | -1.94% |
| August 2026 | $1.25 | $1.49 | $1.83 | +2.43% |
| September 2026 | $1.28 | $1.53 | $1.91 | +3.04% |
| October 2026 | $1.26 | $1.52 | $1.91 | -0.62% |
| November 2026 | $1.27 | $1.54 | $1.94 | +1.20% |
| December 2026 | $1.34 | $1.63 | $2.06 | +5.48% |
Click any year to see its month-by-month BOLD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BOLD to range from $1.05 to $2.06 through 2026. The $1.47 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BOLD price prediction for 2027 points to an average of $1.68 (low $1.33, high $2.25) — a potential gain of +14% on today's $1.47. A consolidation phase looks the most probable path here.
In 2028, BOLD is projected to trade between $1.31 and $2.37, averaging $1.71 — a potential gain of +16% from today's $1.47. That is up +2% on the projected 2027 average. Price action looks broadly range-bound.
Boundless Bio, Inc.'s 2029 outlook centres on $1.68, within a $1.27 to $2.40 range. That is -1% versus the projected 2028 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, BOLD could reach as high as $2.52, with a base case around $1.72 and support toward $1.27 — roughly +17% from $1.47. Price action looks broadly range-bound.
Expect BOLD to range from $1.45 to $2.99 through 2031. The $2.00 average target implies a +36% move from current prices. That is up +16% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The BOLD price prediction for 2032 points to an average of $2.30 (low $1.63, high $3.49) — a potential gain of +56% on today's $1.47. Momentum favours further upside here.
In 2033, BOLD is projected to trade between $1.72 and $3.79, averaging $2.45 — a potential gain of +67% from today's $1.47. That is up +7% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Boundless Bio, Inc.'s 2034 outlook centres on $2.47, within a $1.71 to $3.89 range. That is up +1% on the projected 2033 average. That marks a +68% change versus current levels. Momentum favours further upside here.
By 2035, BOLD could reach as high as $3.99, with a base case around $2.50 and support toward $1.70 — roughly +70% from $1.47. Buyers look set to stay in control over this stretch.
Expect BOLD to range from $2.20 to $5.88 through 2040. The $3.46 average target implies a +136% move from current prices. That is up +39% on the projected 2035 average. Momentum favours further upside here.
The BOLD price prediction for 2050 points to an average of $6.76 (low $3.82, high $12.56) — a potential gain of +360% on today's $1.47. Buyers look set to stay in control over this stretch.
Investing $1,000 in BOLD today (≈ 680.272109 BOLD) could be worth
$4,598.72
+$3,598.72 (+360%) by 2050 · US Dollar
Based on the average projected BOLD price of $6.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BOLDwould be worth at today's price.
$1,000 invested in BOLD on May 27, 2025 (≈ 769.230797 BOLD) would be worth
$1,130.77
+$130.77 (+13.1%) today · 1.13× · US Dollar
Based on a BOLD entry price of $1.3 vs. today's $1.47.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.42 | $1,035.21 | +3.5% |
| 1 month ago | $1.47 | $1,000 | -0.0% |
| 3 months ago | $1.16 | $1,267.24 | +26.7% |
| 6 months ago | $1.17 | $1,256.41 | +25.6% |
| 1 year ago | $1.3 | $1,130.77 | +13.1% |
| All time (2.2y) ago | $14.25 | $103.16 | -89.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BOLD forecast.
Our base-case forecast reaches $2.90 around 2040.
Implied market cap at $2.90: $65.15M
The multi-year forecast shows NEUTRAL sentiment through 2030, with 2026–2030 averages hovering around the current level (for example, 2026 avg $1.44, 2030 avg $1.66) and a path that becomes more favorable starting in 2031. From 2031 onward, the outlook shifts to BULLISH, with 2031 avg $1.96 and a rising trajectory through 2032–2035 (2032 avg $2.25, 2033 $2.38, 2034 $2.43, 2035 $2.44). By 2040 the forecast shows an average of $3.38 with a max of $5.82 and ROI of 134.4%; by 2050 the forecast shows an average of $6.63 with a max of $12.55 and ROI of 360.8%.
These figures are estimates and not guarantees. Changes in market conditions and other factors could affect actual outcomes.
Tap a question to reveal the answer.
2030 avg $1.66, min $1.22, max $2.46; ROI 15.5%; sentiment NEUTRAL.
Forecasts show NEUTRAL through 2030, with sentiment rising to BULLISH from 2031 onward (2031 avg $1.96; 2040 avg $3.38; 2050 avg $6.63). These are estimates, not guarantees.
2040 max $5.82, which exceeds $5 in the forecast horizon.
Current price $1.44; Market cap $32.35M.
RSI14 is 50; SMA50 $1.36; SMA200 $1.24; 30-day range $1.19–$1.74; support $1.20; resistance $1.63; sentiment NEUTRAL; annualized volatility 60%.
Boundless Bio, Inc. Community Discussion
0Share your Boundless Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.